Everest Group (NYSE:EG) misses Q3 2026 revenue estimates

Everest Group (NYSE:EG) reported Q3 2026 revenue of $3.71B, missing estimates by 2.2% and down 14% YoY. Adjusted EPS of $7.62 missed estimates by 4.4%. Net premiums earned declined 18.1% YoY. Book value per share grew 4.1% YoY but missed estimates by 8%. The company's market cap is $15B. Management highlighted initiatives like capital return and balance sheet strengthening.

Original reporting
Published Oct 28, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Everest Group (NYSE:EG) misses Q3 2026 revenue estimates — source image
Decision brief

The 30-second read

$EGBearishHigh
01

Why it matters

The earnings miss may prompt analysts to downgrade forecasts and could trigger short-term sell pressure.

02

Market read

First report of Everest Group's Q3 2026 earnings; material for investors in the reinsurance sector.

03

What to watch

High book value per share growth and $634M net investment income could cushion earnings volatility.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Everest Group reported Q3 2026 results that fell short of Wall Street expectations across revenue, EPS, and combined ratio.

Company-level read

Ticker impact

$EGBearishHigh confidence
Context

Q3 2026 revenue and EPS missed consensus estimates, with revenue down 14% YoY to $3.71B and adjusted EPS $7.62 vs $7.97 expected.

Expected impact

downward pressure as investors price in the revenue and EPS shortfall

Evidence & confidence

The miss is material for a $15B market‑cap insurer; guidance was not provided, and shares only edged up 1.6% intraday, suggesting limited upside.

Market effects

Insurance sector may face broader scrutiny as earnings miss highlights underwriting pressure.

US equity markets likely see modest downside in reinsurance stocks.

Limited; impact confined to insurers and related financials.

Counterpoint

The miss may be temporary; strong balance sheet and share repurchase program could support the stock.

Key entities

  • Everest Group

    Global reinsurance firm listed on NYSE under ticker EG.

Related articles

$EGMedAI 8/10

Everest Group 3Q 2026: Revenue $3.71B, EPS $6.12— 10-Q Summary

Everest Group reported 3Q 2026 revenue of $3.71B, down 14% YoY, and net income of $233M, down 8.9% YoY. Diluted EPS rose slightly to $6.12. Nine-month premiums earned fell 12.6% to $10.2B, with declines in Reinsurance Treaty and Legacy volumes. The company focused on Reinsurance Treaty and Global Wholesale & Specialty, and launched Annapurna Re. Sales of Canadian, Colombian, and Mexican operations are planned.

$EGMed

Everest To Sell Chile Insurance Unit To AIG

Everest Group (EG) is selling its Chile insurance unit to AIG, marking its final planned divestiture in Latin America. The deal is expected to close in the first half of 2027. Everest's shares rose 2.40% to $410.21, while AIG's shares gained 0.14% to $81.55 on NYSE.

$EGMed

Everest Agrees to Sell Chile Insurance to AIG

Everest Group (NYSE: EG) agreed to sell its Chile insurance business to AIG (NYSE: AIG), completing its exit from Latin American commercial retail insurance. The sale follows the recent completion of Everest's Colombia insurance business sale to AIG. The Chile deal is expected to close in the first half of 2027, pending regulatory approvals.

$EGMed

What Everest Group (EG) Said on Its Q3 Earnings Call

Everest Group reported Q3 earnings, highlighting a $600M increase in casualty reserves, with 2/3 tied to North American business. Reinsurance premiums fell 6% YoY. The company's Global Wholesale & Specialty segment saw 3% premium growth and improved margins. Everest repurchased 1.3M shares and returned $550M to shareholders. Management expects continued competition in catastrophe reinsurance and remains selective in casualty.